SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-349558
Filing Date
2012-08-10
Accepted
2012-08-10 13:46:09
Documents
11
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d364214d10q.htm 10-Q 428316
2 CERTIFICATION PURSUANT TO RULE 13A-14(A) d364214dex311.htm EX-31.1 10670
3 CERTIFICATION PURSUANT TO RULE 13A-14(A) d364214dex312.htm EX-31.2 11094
4 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 d364214dex321.htm EX-32.1 5491
5 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 d364214dex322.htm EX-32.2 5540
  Complete submission text file 0001193125-12-349558.txt   3227790

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT galt-20120630.xml EX-101.INS 312261
7 XBRL TAXONOMY EXTENSION SCHEMA galt-20120630.xsd EX-101.SCH 40433
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE galt-20120630_cal.xml EX-101.CAL 38477
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE galt-20120630_def.xml EX-101.DEF 214916
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE galt-20120630_lab.xml EX-101.LAB 303915
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE galt-20120630_pre.xml EX-101.PRE 253226
Mailing Address 7 WELLS AVENUE STE 34 NEWTON MA 02459
Business Address 7 WELLS AVENUE STE 34 NEWTON MA 02459 617-559-0033
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31791 | Film No.: 121023898
SIC: 2834 Pharmaceutical Preparations